Medication info
Mizartan Plus Tablets 40/12.5 mg (Telmisartan, Hydrochlorothiazide)

Mizartan Plus Tablets 40/12.5 mg (Telmisartan, Hydrochlorothiazide)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
IYeon Pharmaceutical Co., Ltd.
Appearance
White or whitish oval tablets
Packaging
30 tablets (10 tablets/Alu-Alu * 3)
Approval status
Active

MFDS item code 201903560 · Approved 2019.05.29 · Insurance code 658604650

Summary

Main use
Treatment of essential hypertension inadequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg per day of this medicine. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2). Thiazide diuretics should be administered with caution to patients with hepatic dysfunction. Elderly patients No dose adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
IYeon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used in the treatment of essential hypertension, and is particularly helpful for effectively managing blood pressure when telmisartan alone does not adequately control blood pressure.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted and administered separately. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered as separate tablets or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution in patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg per day of this medicine. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2). Thiazide diuretics should be administered with caution to patients with hepatic dysfunction. Elderly patients No dose adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, so discontinuation should be immediate upon confirmation of pregnancy. Patients who are allergic to the ingredients in this medication or have specific liver or kidney diseases should not use it. Elderly patients or those with certain heart, liver, or kidney conditions should use this medication with caution and be careful not to let blood pressure drop too low. Hydrochlorothiazide may increase sensitivity of the skin to sunlight, so exposure to ultraviolet radiation should be minimized during treatment, and any skin changes should be promptly discussed with a physician. Various side effects such as dizziness, headache, indigestion, and rash may occur during treatment; report any unusual symptoms to healthcare professionals immediately. Interactions may occur when used with other antihypertensive medications, certain diuretics, lithium, potassium supplements, etc., so notify your doctor of any other medications you are taking. Women who are pregnant or breastfeeding should not use this medication, and it should be avoided during breastfeeding due to the potential transfer into breast milk. In cases of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may arise, thus seek medical attention immediately for appropriate treatment according to symptoms. This medication has not been established as safe and effective for children under 18 years of age, hence is not recommended. During use, keep out of reach of children, and store in a sealed condition until just prior to administration to maintain quality.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 117 more
  • dizziness
  • fainting
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • abnormal liver function
  • liver disorders
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle cramp
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • taste disturbance
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • malaise
  • increased blood creatine
  • decreased hemoglobin
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • sialadenitis
  • non-melanoma skin cancer
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic alkalosis
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal exudate
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • bile stasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • fever
  • itching
  • myalgia
  • feeling of impending doom
  • headache
  • lip and hand tremors
  • sensory hypersensitivity
  • gum disease
  • dry lips
  • decreased vision
  • hypotension
  • tachycardia
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • facial flushing

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help safely preserve the medication's effectiveness.

Appearance and packaging

Appearance

White or whitish oval tablets

Package unit

30 tablets (10 tablets/Alu-Alu * 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.